drugset
Drugs / Human Anti-D (rh) immunoglobulin
last change Apr 2025 re-read 3 minutes ago

Human Anti-D (rh) immunoglobulin

Developed for
pregnancy disorder
Investigated by
Biopharma Plasma LLC · Ivano-Frankivsk National Medical University · State Institution, Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine

Trials 1

today NCT05245734 · Ph 4
20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT05245734 Feb 2022 → Feb 2025 pregnancy disorder Biopharma Plasma LLC Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human Anti-D (rh) immunoglobulin ClinicalTrials.gov intervention name — accepted as the source's own label NCT05245734 ↗
Action Inhibit “The drug Rhesoglobin blocks the interaction of the fetal erythrocytes RhD antigen and the immune system of the mother” NCT05245734 ↗